
Real-World Application of a Procalcitonin Monitoring Protocol in a Pediatric Intensive Care Unit
Author(s) -
Meghan E. Wagner,
Cory M. Hale,
Jessica E. Ericson,
Lindsay C. Trout
Publication year - 2021
Publication title -
the journal of pediatric pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 15
eISSN - 2331-348X
pISSN - 1551-6776
DOI - 10.5863/1551-6776-26.6.603
Subject(s) - procalcitonin , medicine , discontinuation , antibiotics , antimicrobial stewardship , sepsis , protocol (science) , intensive care medicine , antibiotic stewardship , emergency medicine , antibiotic resistance , pathology , alternative medicine , microbiology and biotechnology , biology
Procalcitonin (PCT) is a biomarker used as an indicator for inflammation and bacterial infections. In October 2018, our PICU implemented a PCT monitoring protocol incorporating cutoffs established in previous studies to help guide antibiotic decision-making in patients undergoing sepsis evaluation. The study objective was to evaluate adherence to the protocol with regard to PCT monitoring and antibiotic use.